Bleeding Disorder News and Research

RSS
Researchers develop new animal model for studying hemophilia A

Researchers develop new animal model for studying hemophilia A

NovoSeven RT in 8 mg vial for hemophilia A or B with inhibitors receives FDA approval

NovoSeven RT in 8 mg vial for hemophilia A or B with inhibitors receives FDA approval

Octapharma USA receives confirmation of orphan drug exclusivity from FDA for wilate

Octapharma USA receives confirmation of orphan drug exclusivity from FDA for wilate

Ipsen, Inspiration receive positive opinion in Europe for orphan drug status of OBI-1 in treatment of hemophilia

Ipsen, Inspiration receive positive opinion in Europe for orphan drug status of OBI-1 in treatment of hemophilia

NYBC urges community to donate blood in recognition of Mother's Day

NYBC urges community to donate blood in recognition of Mother's Day

Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults

Alair Bronchial Thermoplasty System receives FDA approval to treat asthma in adults

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

Scientists discover genetic cause of Quebec Platelet Disorder

Scientists discover genetic cause of Quebec Platelet Disorder

Gene therapy for LCA clears another hurdle: Study

Gene therapy for LCA clears another hurdle: Study

FDA warns about drug mix-ups; drug maker agrees to name change to avoid confusion

FDA warns about drug mix-ups; drug maker agrees to name change to avoid confusion

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Children's Hospital of Philadelphia awarded two grants to research into cellular therapies for blood disorders

Ipsen enters into partnership agreement with Inspiration Biopharmaceuticals

Ipsen enters into partnership agreement with Inspiration Biopharmaceuticals

FDA grants orphan drug exclusivity approval for Octapharma AG's wilate

FDA grants orphan drug exclusivity approval for Octapharma AG's wilate

CSL Behring awards four advocacy grants to patient organizations in the U.S.

CSL Behring awards four advocacy grants to patient organizations in the U.S.

McMaster University launches first online interactive educational program on bleeding disorders

McMaster University launches first online interactive educational program on bleeding disorders

Wyeth pledges more than 40 million IUs of factor concentrates to WFH

Wyeth pledges more than 40 million IUs of factor concentrates to WFH

Lysteda tablets to treat menorrhagia approved by the FDA

Lysteda tablets to treat menorrhagia approved by the FDA

Lack of hemophilia treatment in the developing world costing lives

Lack of hemophilia treatment in the developing world costing lives

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

Novo Nordisk re-launches its changing possibilities in hemophilia campaign

CSL Behring offers new dosage strength of Helixate FS in U.S.

CSL Behring offers new dosage strength of Helixate FS in U.S.